BlackBerry Ltd. provides intelligent security software and services to enterprises and governments world wide. It offers devices and software platform for managing security, mobility and communications among hardware, programs, mobile apps and the IoT. BlackBerry UEM is the only unified endpoint management system to be included on the Department of Defense Information Network Approved Products List. It leverages its extensive technology portfolio to offer best-in-class security, safety and reliability to enterprise customers in growing segments of the cybersecurity, connected transportation, healthcare, financial services and government markets. BlackBerry SecuSUITE received accreditation from the government of Canada. It's extending the functionality of its secure BlackBerry Spark software platform through organic investments as well as strategic acquisitions and partnerships. BlackBerry aligned its software and services business around 2 key market opportunities: Cyber Security & IoT....
+See More2018-03-07 07:34:00 Wednesday ET
President Trump tweets his key decision to oust State Secretary Rex Tillerson after several months of intense disagreement over diplomatic affairs. Trump so
2019-03-17 14:35:00 Sunday ET
U.S. trade rep Robert Lighthizer proposes America to require regular touchpoints to ensure Sino-U.S. trade deal enforcement. America has to maintain the thr
2020-02-02 11:32:00 Sunday ET
Our fintech finbuzz analytic report shines fresh light on the current global economic outlook. As of Winter-Spring 2020, the analytical report delves into t
2019-03-25 17:30:00 Monday ET
America seeks to advance the global energy dominance agenda by toppling Saudi Arabia as the top oil exporter by 2024. The International Energy Agency (IEA)
2024-01-31 14:33:00 Wednesday ET
The new world order of trade helps accomplish non-economic policy goals such as national security and technological dominance. To the extent that freer
2025-10-31 12:26:00 Friday ET
With respect to wider weight loss treatment and obesity treatment, the global market for GLP-1 medications now grows substantially to benefit more than 1 bi